Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Me Raises NOK 10M for Microbiome Precision Medicine

NEW YORK – Norwegian firm Bio-Me announced Tuesday it has raised 10 million Norwegian kroner ($1.2 million) to support its microbiome-based precision medicine clinical programs.

The firm noted in a statement that existing and new investors participated, with new investors contributing the majority of the capital.

Bio-Me said it will use the funding to advance several clinical programs and explore other business opportunities for shorter-term revenue generation.

Oslo-based Bio-Me has developed an analysis tool for the gut microbiome in collaboration with Thermo Fischer Scientific.

Called Precision Microbiome Profiling, the tool uses qPCR to enable analysis of up to 200 samples in two hours, allowing the testing to potentially meet the requirements for clinical diagnostic applications.

"The successful funding round is an important step towards positioning Bio-Me for further growth and being a leader in microbiome-based precision medicine," said Bio-Me CEO Morten Isaksen in a statement.

The firm was awarded €2 million ($2.2 million) last year from the Norwegian Research Council to develop a companion diagnostic test for immune checkpoint inhibitor cancer treatments.

Bio-Me is also collaborating with San Carlos, California-based Siolta Therapeutics to develop a rapid diagnostic test for newborns at risk of developing allergy and asthma, and is collaborating on a study of the long-term effects of COVID-19 infection on the gut microbiome in adolescents.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.